Park Avenue Securities LLC Buys Shares of 331 Chemed Co. (NYSE:CHE)

Park Avenue Securities LLC bought a new stake in shares of Chemed Co. (NYSE:CHE) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 331 shares of the company’s stock, valued at approximately $213,000.

Several other institutional investors also recently bought and sold shares of the stock. One Plus One Wealth Management LLC acquired a new stake in shares of Chemed in the first quarter valued at about $492,000. Signal Advisors Wealth LLC acquired a new stake in shares of Chemed in the first quarter valued at about $495,000. Welch Group LLC acquired a new stake in shares of Chemed in the first quarter valued at about $215,000. Rise Advisors LLC acquired a new stake in shares of Chemed in the first quarter valued at about $26,000. Finally, Mather Group LLC. acquired a new stake in shares of Chemed in the first quarter valued at about $67,000. 95.85% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Chemed news, CEO Kevin J. Mcnamara sold 4,000 shares of the firm’s stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $567.54, for a total transaction of $2,270,160.00. Following the completion of the transaction, the chief executive officer now owns 108,549 shares in the company, valued at $61,605,899.46. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Chemed news, CEO Kevin J. Mcnamara sold 4,000 shares of the firm’s stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $567.54, for a total transaction of $2,270,160.00. Following the completion of the transaction, the chief executive officer now owns 108,549 shares in the company, valued at $61,605,899.46. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Kevin J. Mcnamara sold 1,500 shares of Chemed stock in a transaction that occurred on Thursday, June 6th. The shares were sold at an average price of $544.17, for a total transaction of $816,255.00. Following the completion of the transaction, the chief executive officer now owns 107,049 shares of the company’s stock, valued at approximately $58,252,854.33. The disclosure for this sale can be found here. Insiders sold a total of 5,784 shares of company stock worth $3,240,053 over the last quarter. Company insiders own 3.32% of the company’s stock.

Chemed Stock Up 0.4 %

CHE stock opened at $541.73 on Wednesday. Chemed Co. has a twelve month low of $492.84 and a twelve month high of $654.62. The company has a market cap of $8.20 billion, a PE ratio of 29.16, a price-to-earnings-growth ratio of 2.23 and a beta of 0.43. The business’s 50-day simple moving average is $554.54 and its 200 day simple moving average is $588.55.

Chemed (NYSE:CHE) last released its earnings results on Wednesday, April 24th. The company reported $4.68 earnings per share for the quarter, missing analysts’ consensus estimates of $5.09 by ($0.41). The firm had revenue of $589.23 million for the quarter, compared to analyst estimates of $587.18 million. Chemed had a return on equity of 30.52% and a net margin of 12.36%. On average, equities research analysts anticipate that Chemed Co. will post 21.54 EPS for the current year.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 18th. Shareholders of record on Thursday, May 30th were paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.30%. The ex-dividend date of this dividend was Thursday, May 30th. Chemed’s dividend payout ratio is 8.61%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on CHE shares. Royal Bank of Canada lowered their price target on Chemed from $712.00 to $697.00 and set an “outperform” rating on the stock in a research report on Tuesday, May 21st. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, May 4th.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.